Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc and Livongo Stocks Plunged Today

By Joe Tenebruso – Aug 5, 2020 at 6:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The two companies say a merger could create a new standard in healthcare. Investors aren’t so sure.

What happened

Shares of Teladoc Health (TDOC -1.46%) and Livongo Health (LVGO) fell sharply on Wednesday, after the two tech-focused healthcare companies announced their plans for a merger. By the close of trading, Teladoc and Livongo's stocks were down 19% and 11.4%, respectively. 

So what

Under the terms of the deal, Livongo's shareholders will receive 0.592 shares of Teladoc plus $11.33 in cash for each Livongo share they own. As of Aug. 4, the deal valued Livongo at $18.5 billion.

A person is pointing to a digital stock chart that rises sharply and then falls.

Teladoc and Livongo's stocks fell on news of a potential merger. Image source: Getty Images.

The combined company is projected to generate impressive financial metrics, with pro forma revenue of roughly $1.3 billion in 2020 -- representing year over year growth of 85% -- and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of more than $120 million.

"This highly strategic combination will create the leader in consumer-centered virtual care and provides a unique opportunity to further accelerate the growth of our data-driven member platform and experience," Livongo founder and executive chairman Glen Tullman said in a press release. "By expanding the reach of Livongo's pioneering Applied Health Signals platform and building on Teladoc Health's end-to-end virtual care platform, we'll empower more people to live better and healthier lives."

Now what

Investors, however, were not impressed. Teladoc's shareholders apparently believe the virtual care leader is overpaying for Livongo, whose business does lie somewhat outside Teladoc's core telemedicine offerings. Livongo shareholders, meanwhile, probably would have preferred for the rapidly growing company to remain independent. 

Nevertheless, Livongo and Teladoc's management teams remain adamant that the merger will create value for investors and customers alike. "Together, we will further transform the healthcare experience from preventive care to the most complex cases, bringing "whole person" health to consumers and greater value to our clients and shareholders as a result," Teladoc CEO Jason Gorevic said.

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Livongo Health Inc and Teladoc Health. The Motley Fool has a disclosure policy.

Stocks Mentioned

Teladoc Health Stock Quote
Teladoc Health
$25.66 (-1.46%) $0.38
Livongo Health Inc Stock Quote
Livongo Health Inc

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.